Adam Wufsus/LinkedIn
Oct 3, 2026, 07:20
Adam Wufsus: Novo Nordisk Seeks Medical Liaison for Sickle Cell Disease
Adam Wufsus, Director, Medical Affairs – Rare Blood Disorders at Novo Nordisk, shared a post on LinkedIn:
“I’m pleased to share that I am hiring for an exciting opportunity at Novo Nordisk for a Medical Liaison passionate about advancing care for people living with sickle cell disease (SCD).
If you have a strong interest in SCD, a passion for medical affairs, and are looking to make a meaningful impact, I encourage you to explore this opportunity.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments